Trial
NCT01792635
A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Diabetes Mellitus, Type 2
Intervention
PF-05175157
Why stopped
The study was terminated prematurely on 16 May 2014 due to a safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-16